首页 > 最新文献

Biomedical Research-tokyo最新文献

英文 中文
Targeting of the receptor for advanced glycation end products regulates neutrophil infiltration and extravascular recruitment in mice acute pancreatitis. 靶向晚期糖基化终产物受体调节小鼠急性胰腺炎中性粒细胞浸润和血管外募集。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.S28-S33
M. Merza, T. Faraj, Rawaz Dilzar Tawfiq, Rundk Hwaiz, Harm, Ali Hama, Younis Sadiq Smael
Infiltration of leukocytes and pancreatic acinar cell damaging are good indicators of extreme Acute Pancreatitis (AP). The signaling pathways for inflammation and tissue damage of the pancreas not been elucidated yet. In this study, we evaluated the role of targeting of the Receptor for Advanced Glycation End products (RAGE) signaling in AP. Moreover, we investigated the role of signaling RAGE in AP. C57BL/6 mice were injected with a RAGE inhibitor (anti-RAGE) (500 μg/kg) before induction of taurocholate into the pancreatic duct to induce pancreatitis. Treatment anti-RAGE decreased blood amylase concentration, neutrophil recruitment in the pancreas, hemorrhage and edema formation in pancreatitis decreased by taurocholate. Additionally, anti-RAGE administration decreased the MPO activity in the pancreas and lung induced by taurocholate. Intraperitoneal (IP) injection of anti-RAGE significantly decreased concentrations of CXCL2 and IL-6 in the pancreas and plasma respectively in response to challenges of taurocholate. Finally, RAGE inhibition did not have a direct impact on secretagogue-induced trypsinogen activation in pancreatic acinar cells in vitro. Thus, these findings show new signaling pathways in AP and suggest that RAGE targeting may be an efficient way to improve extreme AP.
白细胞浸润和胰腺腺泡细胞损伤是急性重症胰腺炎(AP)的良好指标。胰腺炎症和组织损伤的信号通路尚未阐明。在本研究中,我们评估了靶向晚期糖基化终产物受体(Receptor for Advanced Glycation End products, RAGE)信号通路在AP中的作用。此外,我们还研究了RAGE信号通路在AP中的作用。C57BL/6小鼠在诱导牛磺胆酸进入胰管前注射RAGE抑制剂(抗RAGE) (500 μg/kg)以诱导胰腺炎。抗rage治疗降低血淀粉酶浓度,胰腺中性粒细胞募集,牛磺酸胆酸降低胰腺炎出血和水肿形成。此外,抗rage可降低牛磺胆酸诱导的胰腺和肺部MPO活性。腹腔注射抗rage可显著降低胰腺和血浆中CXCL2和IL-6的浓度,以应对牛磺胆酸的挑战。最后,在体外实验中,RAGE抑制对促分泌剂诱导的胰腺腺泡细胞胰蛋白酶原激活没有直接影响。因此,这些发现揭示了AP中新的信号通路,并提示RAGE靶向可能是改善极端AP的有效方法。
{"title":"Targeting of the receptor for advanced glycation end products regulates neutrophil infiltration and extravascular recruitment in mice acute pancreatitis.","authors":"M. Merza, T. Faraj, Rawaz Dilzar Tawfiq, Rundk Hwaiz, Harm, Ali Hama, Younis Sadiq Smael","doi":"10.35841/0970-938X.S28-S33","DOIUrl":"https://doi.org/10.35841/0970-938X.S28-S33","url":null,"abstract":"Infiltration of leukocytes and pancreatic acinar cell damaging are good indicators of extreme Acute Pancreatitis (AP). The signaling pathways for inflammation and tissue damage of the pancreas not been elucidated yet. In this study, we evaluated the role of targeting of the Receptor for Advanced Glycation End products (RAGE) signaling in AP. Moreover, we investigated the role of signaling RAGE in AP. C57BL/6 mice were injected with a RAGE inhibitor (anti-RAGE) (500 μg/kg) before induction of taurocholate into the pancreatic duct to induce pancreatitis. Treatment anti-RAGE decreased blood amylase concentration, neutrophil recruitment in the pancreas, hemorrhage and edema formation in pancreatitis decreased by taurocholate. Additionally, anti-RAGE administration decreased the MPO activity in the pancreas and lung induced by taurocholate. Intraperitoneal (IP) injection of anti-RAGE significantly decreased concentrations of CXCL2 and IL-6 in the pancreas and plasma respectively in response to challenges of taurocholate. Finally, RAGE inhibition did not have a direct impact on secretagogue-induced trypsinogen activation in pancreatic acinar cells in vitro. Thus, these findings show new signaling pathways in AP and suggest that RAGE targeting may be an efficient way to improve extreme AP.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"3 1","pages":"28-33"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82053239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimation level of IL-10 and TNF-? in Iraq T1DM patient. IL-10和TNF-?伊拉克的T1DM患者。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.32.3.75-75
Sabreen Ali Mezil, R. Al-Shawk
Tumor Necrosis Factor (TNF-α) also known as differentiation factor, is a key component in inflammatory and immune responses. TNF-α is a pleiotropic proinflammatory cytokine produced in response to infection, inflammation, and environmental stressors by activated macrophages, and lymphocytes. TNF-α has been shown to play a part in the autoimmune cascade that leads to beta cell death in type 1 diabetes, and repeated antibodymediated TNF-α action inhibition has been shown to protect non-obese mice from beta cell death. We tried to demonstrate a correlation between pro-inflammatory and anti-inflammatory cytokines including IL-10 and TNF-α, which are both involved in the pathogenesis of T1D, in children and adolescents under the age of 15 with varying diabetes durations in this study.
肿瘤坏死因子(TNF-α)也被称为分化因子,是炎症和免疫反应的关键成分。TNF-α是一种多效性促炎细胞因子,由活化的巨噬细胞和淋巴细胞对感染、炎症和环境应激反应产生。TNF-α已被证明在导致1型糖尿病患者β细胞死亡的自身免疫级联反应中发挥作用,并且反复抗体介导的TNF-α作用抑制已被证明可保护非肥胖小鼠免于β细胞死亡。在这项研究中,我们试图证明在患有不同糖尿病病程的15岁以下儿童和青少年中,促炎和抗炎细胞因子包括IL-10和TNF-α之间的相关性,它们都参与了T1D的发病机制。
{"title":"Estimation level of IL-10 and TNF-? in Iraq T1DM patient.","authors":"Sabreen Ali Mezil, R. Al-Shawk","doi":"10.35841/0970-938X.32.3.75-75","DOIUrl":"https://doi.org/10.35841/0970-938X.32.3.75-75","url":null,"abstract":"Tumor Necrosis Factor (TNF-α) also known as differentiation factor, is a key component in inflammatory and immune responses. TNF-α is a pleiotropic proinflammatory cytokine produced in response to infection, inflammation, and environmental stressors by activated macrophages, and lymphocytes. TNF-α has been shown to play a part in the autoimmune cascade that leads to beta cell death in type 1 diabetes, and repeated antibodymediated TNF-α action inhibition has been shown to protect non-obese mice from beta cell death. We tried to demonstrate a correlation between pro-inflammatory and anti-inflammatory cytokines including IL-10 and TNF-α, which are both involved in the pathogenesis of T1D, in children and adolescents under the age of 15 with varying diabetes durations in this study.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"12 4 1","pages":"75-75"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76110672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of UGT2B7 Gene Polymorphism with Clinical Pediatric Epileptic patients on Sodium Valproate Monotherapy 临床儿童癫痫患者UGT2B7基因多态性对丙戊酸钠单药治疗的影响
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.S10-S15
ith Pb, Sachidan, A. Adiga, U. Adiga, V. Shenoy, S. Kumari, P. Shetty, S. Shetty, K. Sharmila
Background: Pediatric epilepsy comprises of a chronic neurological disorders characterized by recurrent seizure attack. Sodium valproate is one of the common anti-epileptic drugs used in the treatment. Glucuronide conjugation is the major metabolic pathway of sodium valproate, carried out by the enzyme Uridine 5’-diphospho (UDP) glucuronosyl transferase (UGT) whose genetic polymorphisms may alter clinical outcome. Aim: To find the association between UGT2B7 genetic polymorphism and clinical outcome in terms of efficacy and tolerability in pediatric epileptic patients on sodium valproate monotherapy. Methods and Materials: In this cohort study, 75 pediatric epileptic patients aged 2-18 years receiving sodium valproate monotherapy for past one month were included from Justice K S Hegde Charitable Hospital, Mangalore, India after obtaining informed consent. Genetic polymorphism patterns of UGT2B7 (C161T, A268G, G211T) was evaluated by PCR-RFLP. Clinical outcome was measured in terms of responders and non-responders based on seizure control during the 6 month observation period. Tolerability was measured by estimating the hepatic, renal and other lab parameters. Clinical outcome in different UGT genotypes was compared by Chi square test. P value <0.05 was considered as significant. Results: Out of 75 patients, CC (41.3%), CT (38.7%), TT (20%) pattern was observed in UGT2B7 (C161T) gene, AA(14.7%), AG(42.7%), GG(42.7%) in (A268G) gene and GG(80%), GT(18.7%), TT(1.3%) in (G211T) gene. It was found that there was no statistical difference in clinical outcome with different UGT2B7 genetic polymorphism patterns. Conclusion: We conclude from our study that genetic polymorphism of UGT2B7 doesn’t have any role on the clinical outcome of epilepsy.
背景:儿童癫痫是一种以反复发作为特征的慢性神经系统疾病。丙戊酸钠是常用的抗癫痫药物之一。葡萄糖醛酸缀合是丙戊酸钠的主要代谢途径,由尿苷5 ' -二磷酸(UDP)葡萄糖醛酸转移酶(UGT)进行,其遗传多态性可能改变临床结果。目的:探讨UGT2B7基因多态性与小儿癫痫患者丙戊酸钠单药疗效和耐受性的关系。方法和材料:在本队列研究中,在获得知情同意后,从印度芒格洛尔Justice K S Hegde慈善医院纳入75例2-18岁接受丙戊酸钠单药治疗过去一个月的儿童癫痫患者。采用PCR-RFLP方法分析UGT2B7基因(C161T、A268G、G211T)的遗传多态性模式。在6个月的观察期内,以发作控制为基础,以反应者和无反应者来衡量临床结果。通过估计肝脏、肾脏和其他实验室参数来测量耐受性。采用卡方检验比较不同UGT基因型患者的临床结果。P值<0.05为差异有统计学意义。结果:75例患者中,UGT2B7 (C161T)基因中存在CC(41.3%)、CT(38.7%)、TT(20%), (A268G)基因中存在AA(14.7%)、AG(42.7%)、GG(42.7%), (G211T)基因中存在GG(80%)、GT(18.7%)、TT(1.3%)。不同UGT2B7基因多态性的临床转归无统计学差异。结论:UGT2B7基因多态性对癫痫的临床预后无影响。
{"title":"Effect of UGT2B7 Gene Polymorphism with Clinical Pediatric Epileptic patients on Sodium Valproate Monotherapy","authors":"ith Pb, Sachidan, A. Adiga, U. Adiga, V. Shenoy, S. Kumari, P. Shetty, S. Shetty, K. Sharmila","doi":"10.35841/0970-938X.S10-S15","DOIUrl":"https://doi.org/10.35841/0970-938X.S10-S15","url":null,"abstract":"Background: Pediatric epilepsy comprises of a chronic neurological disorders characterized by recurrent seizure attack. Sodium valproate is one of the common anti-epileptic drugs used in the treatment. Glucuronide conjugation is the major metabolic pathway of sodium valproate, carried out by the enzyme Uridine 5’-diphospho (UDP) glucuronosyl transferase (UGT) whose genetic polymorphisms may alter clinical outcome. Aim: To find the association between UGT2B7 genetic polymorphism and clinical outcome in terms of efficacy and tolerability in pediatric epileptic patients on sodium valproate monotherapy. Methods and Materials: In this cohort study, 75 pediatric epileptic patients aged 2-18 years receiving sodium valproate monotherapy for past one month were included from Justice K S Hegde Charitable Hospital, Mangalore, India after obtaining informed consent. Genetic polymorphism patterns of UGT2B7 (C161T, A268G, G211T) was evaluated by PCR-RFLP. Clinical outcome was measured in terms of responders and non-responders based on seizure control during the 6 month observation period. Tolerability was measured by estimating the hepatic, renal and other lab parameters. Clinical outcome in different UGT genotypes was compared by Chi square test. P value <0.05 was considered as significant. Results: Out of 75 patients, CC (41.3%), CT (38.7%), TT (20%) pattern was observed in UGT2B7 (C161T) gene, AA(14.7%), AG(42.7%), GG(42.7%) in (A268G) gene and GG(80%), GT(18.7%), TT(1.3%) in (G211T) gene. It was found that there was no statistical difference in clinical outcome with different UGT2B7 genetic polymorphism patterns. Conclusion: We conclude from our study that genetic polymorphism of UGT2B7 doesn’t have any role on the clinical outcome of epilepsy.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"17 1","pages":"10-15"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75241050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cellular expression and subcellular localization of diacylglycerol kinase γ in rat brain. 二酰基甘油激酶γ在大鼠脑中的细胞表达和亚细胞定位。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.2220/biomedres.42.33
Yasukazu Hozumi, Tomoyuki Nakano, Kaoru Goto

Gq protein-coupled receptors lead to activation of phospholipase C, which triggers phosphoinositide signaling. Diacylglycerol (DG) is one of the phosphoinositide metabolites and serves as a second messenger. Diacylglycerol kinase (DGK) phosphorylates DG to produce another second messenger phosphatidic acid. Of the DGK family, DGKγ is predominantly expressed in the brain at the mRNA level. Recent studies have shown the expression of DGKγ in vascular endothelial cells and adrenal medullary cells at the protein level, although its detailed cellular expression pattern and subcellular localization in the brain remain to be determined. In the present study, we addressed this point using specific DGKγ antibody. DGKγ was expressed in both projection neurons and interneurons in the cerebral cortex, hippocampal formation, and cerebellum. In cerebellar Purkinje cells, DGKγ was distributed to the soma and dendrites. Fractionation study revealed that DGKγ was enriched in the internal membranes containing the endoplasmic reticulum and Golgi complex. In immunoelectron microscopy, DGKγ was localized throughout the smooth endoplasmic reticulum system. These findings suggest that DGKγ shows unique cellular expression pattern in the brain and distinct subcellular localization different from other DGK isozymes.

Gq蛋白偶联受体导致磷脂酶C的激活,从而触发磷酸肌苷信号传导。二酰基甘油(DG)是磷酸肌醇代谢产物之一,作为第二信使。二酰基甘油激酶(DGK)磷酸化DG产生另一种第二信使磷脂酸。在DGK家族中,DGKγ主要以mRNA水平在大脑中表达。最近的研究表明,DGKγ在血管内皮细胞和肾上腺髓细胞中以蛋白水平表达,但其在大脑中的详细细胞表达模式和亚细胞定位仍有待确定。在本研究中,我们使用特异性DGKγ抗体解决了这一点。DGKγ在大脑皮层、海马和小脑的投射神经元和中间神经元中均有表达。在小脑浦肯野细胞中,DGKγ分布于胞体和树突。分离研究表明,DGKγ在含有内质网和高尔基复合体的内膜中富集。在免疫电镜下,DGKγ定位于整个光滑内质网系统。这些发现表明DGKγ在大脑中具有独特的细胞表达模式和不同于其他DGK同工酶的亚细胞定位。
{"title":"Cellular expression and subcellular localization of diacylglycerol kinase γ in rat brain.","authors":"Yasukazu Hozumi,&nbsp;Tomoyuki Nakano,&nbsp;Kaoru Goto","doi":"10.2220/biomedres.42.33","DOIUrl":"https://doi.org/10.2220/biomedres.42.33","url":null,"abstract":"<p><p>Gq protein-coupled receptors lead to activation of phospholipase C, which triggers phosphoinositide signaling. Diacylglycerol (DG) is one of the phosphoinositide metabolites and serves as a second messenger. Diacylglycerol kinase (DGK) phosphorylates DG to produce another second messenger phosphatidic acid. Of the DGK family, DGKγ is predominantly expressed in the brain at the mRNA level. Recent studies have shown the expression of DGKγ in vascular endothelial cells and adrenal medullary cells at the protein level, although its detailed cellular expression pattern and subcellular localization in the brain remain to be determined. In the present study, we addressed this point using specific DGKγ antibody. DGKγ was expressed in both projection neurons and interneurons in the cerebral cortex, hippocampal formation, and cerebellum. In cerebellar Purkinje cells, DGKγ was distributed to the soma and dendrites. Fractionation study revealed that DGKγ was enriched in the internal membranes containing the endoplasmic reticulum and Golgi complex. In immunoelectron microscopy, DGKγ was localized throughout the smooth endoplasmic reticulum system. These findings suggest that DGKγ shows unique cellular expression pattern in the brain and distinct subcellular localization different from other DGK isozymes.</p>","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"42 1","pages":"33-42"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25353635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New conjugated monoclonal antibodies: Area of a promising therapy in metastatic breast cancer. 新的偶联单克隆抗体:转移性乳腺癌的一个有希望的治疗领域。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.32.1.15-18
EL Hazzaz Reda, Oualla Karima, Darif Khadija, Sqalli Houssaini Med, Amaadour Lamiae, B. Zineb, A. Samia, M. Nawfel
Following advances in molecular biology and better understanding of the mechanisms of carcinogenesis, new therapies have been developed with new agents that target tumor cells with minimal effects on normal cells. Monoclonal antibodies represent the model of success of this approach; they are directed against antigens selectively expressed by tumor cells. The conjugation of these monoclonal antibodies with potent cytotoxic drugs makes it possible to improve their efficacy while maintaining a favorable tolerance profile. T-DM1 (Trastuzumab Emtansine) is the first example of advanced development of a conjugated antibody. It works by associating an antitumor activity specific to trastuzumab with the efficient delivery of a potent cytotoxic, delivered selectively and targeted to cancer cells overexpressing HER2. Unlike trastuzumab emtansine, trastuzumab deruxtecan has a released payload that easily crosses the cell membrane, which potentially allows for a potent cytotoxic effect on neighboring tumor cells regardless of target expression. In addition, the released payload has a short half-life, which is designed to minimize systemic exposure. DESTINY breast-01 study has demonstrated the efficacy of trastuzumab deruxtecan in patients with HER2- positive metastatic breast cancer previously treated with trastuzumab emtansine. Trastuzumab deruxtecan is FDA-approved. Sacituzumab govitecan (sacituzumab govitecan-hziy) is a conjugated monoclonal antibody developed by site-specific conjugation of the active metabolite of irinotecan, SN-38 (govitecan). It has demonstrated promising activity in advanced lines for triple-negative breast cancer in a phase I/II study and recently in ASCENT trial phase III. Conjugated monoclonal antibodies have been shown to be effective in different subtypes of metastatic breast cancer.
随着分子生物学的进步和对癌变机制的更好理解,新的治疗方法已经开发出来,新的药物靶向肿瘤细胞,对正常细胞的影响最小。单克隆抗体代表了这种方法的成功模式;它们直接针对肿瘤细胞选择性表达的抗原。这些单克隆抗体与强效细胞毒性药物的结合使得在保持良好耐受性的同时提高其疗效成为可能。T-DM1(曲妥珠单抗Emtansine)是高级缀合抗体开发的第一个例子。它的工作原理是将曲妥珠单抗特异性的抗肿瘤活性与有效递送强效细胞毒性结合起来,选择性地递送并靶向过表达HER2的癌细胞。与曲妥珠单抗emtansine不同,曲妥珠单抗deruxtecan有一种释放的有效载荷,可以很容易地穿过细胞膜,这可能允许对邻近肿瘤细胞产生有效的细胞毒性作用,而不管目标表达如何。此外,释放的有效载荷具有较短的半衰期,这是为了尽量减少系统暴露。DESTINY breast-01研究表明,曲妥珠单抗德鲁德替康对先前接受曲妥珠单抗恩坦辛治疗的HER2阳性转移性乳腺癌患者有效。Trastuzumab deruxtecan是fda批准的。Sacituzumab govitecan (Sacituzumab govitecan-hziy)是一种偶联单克隆抗体,通过位点特异性偶联伊立替康SN-38 (govitecan)的活性代谢物而开发。在一项I/II期研究和最近的ASCENT III期试验中,它在晚期三阴性乳腺癌的治疗中显示出了有希望的活性。偶联单克隆抗体已被证明对转移性乳腺癌的不同亚型有效。
{"title":"New conjugated monoclonal antibodies: Area of a promising therapy in metastatic breast cancer.","authors":"EL Hazzaz Reda, Oualla Karima, Darif Khadija, Sqalli Houssaini Med, Amaadour Lamiae, B. Zineb, A. Samia, M. Nawfel","doi":"10.35841/0970-938X.32.1.15-18","DOIUrl":"https://doi.org/10.35841/0970-938X.32.1.15-18","url":null,"abstract":"Following advances in molecular biology and better understanding of the mechanisms of carcinogenesis, new therapies have been developed with new agents that target tumor cells with minimal effects on normal cells. Monoclonal antibodies represent the model of success of this approach; they are directed against antigens selectively expressed by tumor cells. The conjugation of these monoclonal antibodies with potent cytotoxic drugs makes it possible to improve their efficacy while maintaining a favorable tolerance profile. T-DM1 (Trastuzumab Emtansine) is the first example of advanced development of a conjugated antibody. It works by associating an antitumor activity specific to trastuzumab with the efficient delivery of a potent cytotoxic, delivered selectively and targeted to cancer cells overexpressing HER2. Unlike trastuzumab emtansine, trastuzumab deruxtecan has a released payload that easily crosses the cell membrane, which potentially allows for a potent cytotoxic effect on neighboring tumor cells regardless of target expression. In addition, the released payload has a short half-life, which is designed to minimize systemic exposure. DESTINY breast-01 study has demonstrated the efficacy of trastuzumab deruxtecan in patients with HER2- positive metastatic breast cancer previously treated with trastuzumab emtansine. Trastuzumab deruxtecan is FDA-approved. Sacituzumab govitecan (sacituzumab govitecan-hziy) is a conjugated monoclonal antibody developed by site-specific conjugation of the active metabolite of irinotecan, SN-38 (govitecan). It has demonstrated promising activity in advanced lines for triple-negative breast cancer in a phase I/II study and recently in ASCENT trial phase III. Conjugated monoclonal antibodies have been shown to be effective in different subtypes of metastatic breast cancer.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"67 1","pages":"15-18"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84047698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of application of navigation system to odontogenic benign tumors with maxilla. 导航系统在上颌骨牙源性良性肿瘤中的应用。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.32.2.37-41
Julia Koseki, Takahiro Abe, Y. Miyamoto, M. Kashiwagi, Makiko Ishibashi, Asako Taniguchi, H. Suenaga, H. Abe, Masanobu Abe, K. Hoshi
Oral and maxillofacial region has a complicated anatomy with critical nerves and arteries inside. Therefore, oral surgeons sometimes do not have enough operative fields during surgeries and anatomic changes caused by tumors and fractures make the surgeries more difficult. The application of navigation system in oral surgery has started in such cases that tumors are close to cranial base and have risks to damage important anatomical structures like nerves and vessels. It can make doctors more confident with their operations and decrease operative risks, but the use is still limited because of several obstacles. In this context, we applied navigation system to the operations of removing recurrent ameloblastoma on sphenoid bone and myxoma. The surgeries we performed with navigation system were successful and we have not had any postoperative complications at all. This report presents to use navigation system to remove benign tumor that occurs in deep area of craniofacial bone completely in a minimally invasive way.
口腔颌面区解剖结构复杂,内有重要的神经和动脉。因此,口腔外科医生在手术中有时没有足够的手术视野,肿瘤和骨折引起的解剖变化使手术更加困难。导航系统在口腔外科中的应用,是在肿瘤靠近颅底,有损伤神经、血管等重要解剖结构风险的情况下开始的。它可以使医生对他们的手术更有信心,降低手术风险,但由于一些障碍,它的使用仍然有限。在这种情况下,我们应用导航系统手术切除复发性蝶骨成釉细胞瘤和黏液瘤。我们使用导航系统进行的手术很成功,没有出现任何术后并发症。本报告介绍利用导航系统以微创方式完全切除发生在颅面骨深部的良性肿瘤。
{"title":"Use of application of navigation system to odontogenic benign tumors with maxilla.","authors":"Julia Koseki, Takahiro Abe, Y. Miyamoto, M. Kashiwagi, Makiko Ishibashi, Asako Taniguchi, H. Suenaga, H. Abe, Masanobu Abe, K. Hoshi","doi":"10.35841/0970-938X.32.2.37-41","DOIUrl":"https://doi.org/10.35841/0970-938X.32.2.37-41","url":null,"abstract":"Oral and maxillofacial region has a complicated anatomy with critical nerves and arteries inside. Therefore, oral surgeons sometimes do not have enough operative fields during surgeries and anatomic changes caused by tumors and fractures make the surgeries more difficult. The application of navigation system in oral surgery has started in such cases that tumors are close to cranial base and have risks to damage important anatomical structures like nerves and vessels. It can make doctors more confident with their operations and decrease operative risks, but the use is still limited because of several obstacles. In this context, we applied navigation system to the operations of removing recurrent ameloblastoma on sphenoid bone and myxoma. The surgeries we performed with navigation system were successful and we have not had any postoperative complications at all. This report presents to use navigation system to remove benign tumor that occurs in deep area of craniofacial bone completely in a minimally invasive way.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"7 1","pages":"37-41"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90361429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cellular expression of CD26/dipeptidyl peptidase IV. CD26/二肽基肽酶IV的细胞表达。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.2220/biomedres.42.229
Toshihiko Iwanaga, Junko Nio-Kobayashi

Dipeptidyl peptidase 4 (DPP4), a serine protease expressed on luminal and apical cell membrane, is identical to the lymphocyte cell surface protein CD26. DPP4 rapidly deactivates hormones and cytokines by cleaving their NH2-terminal dipeptides. Its functions are based on membrane digestion and/or binding of bioactive peptides, signal molecules, and extracellular matrix components. The soluble form is also present in body fluids such as serum, urine, semen, and synovial fluid. The extremely broad distribution of CD26/DPP4 indicates its divergent roles depending on cell type and activated conditions. The cellular localization was earlier examined by enzyme histochemistry and subsequently by immunohistochemistry. Although immunohistochemical analyses are higher in specificity and easier to use at electron microscopic levels than enzyme histochemistry, the immunoreaction is considerably affected by the animal species, types of tissue sections, and specificity of antibodies. Understanding of the functional significance and advancement of its clinical use (diagnosis and treatment of diseases) require precise information on the cellular distribution including subcellular localization and pathological changes. This short review summarizes in particular immunohistochemical findings on CD26/DPP4.

二肽基肽酶4 (Dipeptidyl peptidase 4, DPP4)是一种丝氨酸蛋白酶,与淋巴细胞表面蛋白CD26相同,表达于管腔和根尖细胞膜上。DPP4通过切割激素和细胞因子的nh2末端二肽而迅速使其失活。它的功能是基于膜消化和/或结合生物活性肽、信号分子和细胞外基质成分。可溶性形式也存在于体液中,如血清、尿液、精液和滑液。CD26/DPP4的极广泛分布表明其根据细胞类型和激活条件的不同而发挥不同的作用。细胞定位早期用酶组织化学检查,随后用免疫组织化学检查。虽然免疫组织化学分析的特异性比酶组织化学更高,在电镜水平上也更容易使用,但免疫反应在很大程度上受到动物种类、组织切片类型和抗体特异性的影响。了解其功能意义及其临床应用(疾病的诊断和治疗)的进展需要精确的细胞分布信息,包括亚细胞定位和病理变化。这篇简短的综述总结了CD26/DPP4的免疫组化结果。
{"title":"Cellular expression of CD26/dipeptidyl peptidase IV.","authors":"Toshihiko Iwanaga,&nbsp;Junko Nio-Kobayashi","doi":"10.2220/biomedres.42.229","DOIUrl":"https://doi.org/10.2220/biomedres.42.229","url":null,"abstract":"<p><p>Dipeptidyl peptidase 4 (DPP4), a serine protease expressed on luminal and apical cell membrane, is identical to the lymphocyte cell surface protein CD26. DPP4 rapidly deactivates hormones and cytokines by cleaving their NH<sub>2</sub>-terminal dipeptides. Its functions are based on membrane digestion and/or binding of bioactive peptides, signal molecules, and extracellular matrix components. The soluble form is also present in body fluids such as serum, urine, semen, and synovial fluid. The extremely broad distribution of CD26/DPP4 indicates its divergent roles depending on cell type and activated conditions. The cellular localization was earlier examined by enzyme histochemistry and subsequently by immunohistochemistry. Although immunohistochemical analyses are higher in specificity and easier to use at electron microscopic levels than enzyme histochemistry, the immunoreaction is considerably affected by the animal species, types of tissue sections, and specificity of antibodies. Understanding of the functional significance and advancement of its clinical use (diagnosis and treatment of diseases) require precise information on the cellular distribution including subcellular localization and pathological changes. This short review summarizes in particular immunohistochemical findings on CD26/DPP4.</p>","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"42 6","pages":"229-237"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39749586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Prevalence of various anomalies of costal element at cervico-thoracic junction in and around lucknow region of uttar pradesh: A radiological study. 在北方邦勒克瑙地区及其周围的颈胸交界处,各种肋部异常的患病率:一项放射学研究。
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.32.1.7-14
A. Rani, J. Chopra, Rana Ravneesh Singh, P. Bajpai
Morphological diversities of the costal element at the cervico-thoracic junction adversely affect the positioning of its various neurovascular and soft tissue structures which form the etiological basis of symptoms in many cases of a non-traumatic type of Thoracic Outlet Syndrome (TOS). These rib variants represent disturbances of early organogenesis and are associated with stillbirths, childhood cancers, and several other congenital malformations. The present study aims to document the current prevalence, gender preferences, and laterality associations of various costal anomalies at the thoracic outlet in the reference population. A retrospective cross-sectional analytical study was conducted on 1474 PA skiagrams of the cervico-thoracic region, which comprised 919 males and 555 females of zero days to 73-year age. In 13.02% population, costal element exhibited anomalous development. Anomalies of the costal process of C7 vertebra showed higher(12.20%) prevalence compared to the thoracic first(0.81%). Elongation of the cervical 7 transverse process was most common(10.71%) followed by cervical rib(1.49%), rudimentary first rib (0.54%), and fusion of first and second ribs(0.27%). Cervical 7 costal anomalies showed a significant inclination towards females. No significant association with laterality and sidedness was observed for any of the anomalies. The study highlights a higher prevalence of an elongated transverse process of C7 compared to cervical rib and first rib anomalies in the reference population.
颈胸交界处肋部的形态多样性对其各种神经血管和软组织结构的定位产生不利影响,这些结构形成了许多非创伤型胸廓出口综合征(TOS)症状的病因学基础。这些肋骨变异代表了早期器官发生的紊乱,并与死产、儿童癌症和其他几种先天性畸形有关。本研究旨在记录当前患病率,性别偏好,以及在参考人群胸廓出口的各种肋侧异常的相关性。回顾性横断面分析研究了1474例颈胸区PA skiogram,其中男性919例,女性555例,年龄从0天到73岁。13.02%的人群肋部发育异常。C7椎体肋突异常发生率(12.20%)高于胸突异常发生率(0.81%)。颈7横突伸长最为常见(10.71%),其次是颈肋(1.49%)、第一肋骨发育不全(0.54%)和第一肋骨与第二肋骨融合(0.27%)。颈肋异常明显偏向女性。没有观察到任何异常与侧边性和侧边性的显著关联。该研究强调,在参考人群中,与颈肋和第一肋异常相比,C7横突延长的患病率更高。
{"title":"Prevalence of various anomalies of costal element at cervico-thoracic junction in and around lucknow region of uttar pradesh: A radiological study.","authors":"A. Rani, J. Chopra, Rana Ravneesh Singh, P. Bajpai","doi":"10.35841/0970-938X.32.1.7-14","DOIUrl":"https://doi.org/10.35841/0970-938X.32.1.7-14","url":null,"abstract":"Morphological diversities of the costal element at the cervico-thoracic junction adversely affect the positioning of its various neurovascular and soft tissue structures which form the etiological basis of symptoms in many cases of a non-traumatic type of Thoracic Outlet Syndrome (TOS). These rib variants represent disturbances of early organogenesis and are associated with stillbirths, childhood cancers, and several other congenital malformations. The present study aims to document the current prevalence, gender preferences, and laterality associations of various costal anomalies at the thoracic outlet in the reference population. A retrospective cross-sectional analytical study was conducted on 1474 PA skiagrams of the cervico-thoracic region, which comprised 919 males and 555 females of zero days to 73-year age. In 13.02% population, costal element exhibited anomalous development. Anomalies of the costal process of C7 vertebra showed higher(12.20%) prevalence compared to the thoracic first(0.81%). Elongation of the cervical 7 transverse process was most common(10.71%) followed by cervical rib(1.49%), rudimentary first rib (0.54%), and fusion of first and second ribs(0.27%). Cervical 7 costal anomalies showed a significant inclination towards females. No significant association with laterality and sidedness was observed for any of the anomalies. The study highlights a higher prevalence of an elongated transverse process of C7 compared to cervical rib and first rib anomalies in the reference population.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"35 1","pages":"7-14"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78121977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect on malondialdehyde, superoxide dismutase and reduced glutathione and its metabolizing enzymes in vitamin D deficient newly diagnosed Type- 2 diabetic patients. 维生素D缺乏对新诊断2型糖尿病患者丙二醛、超氧化物歧化酶、还原性谷胱甘肽及其代谢酶的影响
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.32.1.1-6
Kuldip Singh
Background: India, with 32 million diabetic individuals, currently has the highest incidence of diabetes worldwide. Recently, World Health Organization (WHO) reported that these numbers are predicted to increase to 80 million by the year 2030. Vitamin D regulates glucose metabolism and oxidative stress is a well-established factor of this multi-factorial disease. Aim: Present, study was designed to evaluate certain oxidative stress markers like malondialdehyde, superoxide dismutase, reduced glutathione, glutathione reductase, Glutathione Peroxidase (GPx) along with total antioxidant activity in vitamin D deficient newly diagnosed Type 2 diabetics. Methods: 150 vitamin D deficient newly diagnosed type 2 diabetics’ and equal number of healthy subjects of both genders were recruited. Fasting blood was collected for evaluation of glucose, 25(OH) D and oxidative stress markers. Results: Significant (P<0.01) increase in malondialdehyde by 51.03% while a significant decrease in oxidative stress markers like SOD, GSH, GR, GPx and total antioxidant activity by 27.91 (P<0.05), 26.14% (P<0.05), 32.04% (P<0.01), 25.41% (P<0.05) and 35.85% (P<0.01) respectively was recorded in vitamin D deficient newly diagnosed type 2 diabetics with respect to healthy controls. Conclusions: A fore mentioned observations suggested that vitamin-D deficient newly diagnosed Type-2 diabetics of North-West Indian’s are associated with oxidative stress, a hallmark of various diseases like Diabetes Mellitus, cardiovascular diseases, osteoporosis etc. Therapeutic interventions in combinations of lifestyle and dietary modification might be beneficial to prevent further risk of development of Diabetes Mellitus and cardiovascular diseases like atherosclerosis in North-West Indians.
背景:印度有3200万糖尿病患者,目前是世界上糖尿病发病率最高的国家。最近,世界卫生组织(卫生组织)报告说,预计到2030年这些数字将增加到8 000万。维生素D调节葡萄糖代谢和氧化应激是这种多因素疾病的一个公认因素。目的:本研究旨在评价新诊断的维生素D缺乏症2型糖尿病患者丙二醛、超氧化物歧化酶、还原性谷胱甘肽、谷胱甘肽还原酶、谷胱甘肽过氧化物酶(GPx)等氧化应激标志物与总抗氧化活性的关系。方法:招募150例维生素D缺乏症新诊断的2型糖尿病患者和同等数量的健康受试者。采集空腹血,评估葡萄糖、25(OH) D和氧化应激标志物。结果:与健康对照组相比,维生素D缺乏的新诊断2型糖尿病患者丙二醛含量显著(P<0.01)升高51.03%,氧化应激标志物SOD、GSH、GR、GPx和总抗氧化活性分别显著降低27.91% (P<0.05)、26.14% (P<0.05)、32.04% (P<0.01)、25.41% (P<0.05)和35.85% (P<0.01)。结论:前面提到的观察结果表明,西北印度人新诊断的维生素d缺乏症2型糖尿病患者与氧化应激有关,氧化应激是糖尿病、心血管疾病、骨质疏松症等多种疾病的标志。生活方式和饮食调整相结合的治疗干预可能有助于预防西北印度人进一步患糖尿病和心血管疾病(如动脉粥样硬化)的风险。
{"title":"Effect on malondialdehyde, superoxide dismutase and reduced glutathione and its metabolizing enzymes in vitamin D deficient newly diagnosed Type- 2 diabetic patients.","authors":"Kuldip Singh","doi":"10.35841/0970-938X.32.1.1-6","DOIUrl":"https://doi.org/10.35841/0970-938X.32.1.1-6","url":null,"abstract":"Background: India, with 32 million diabetic individuals, currently has the highest incidence of diabetes worldwide. Recently, World Health Organization (WHO) reported that these numbers are predicted to increase to 80 million by the year 2030. Vitamin D regulates glucose metabolism and oxidative stress is a well-established factor of this multi-factorial disease. Aim: Present, study was designed to evaluate certain oxidative stress markers like malondialdehyde, superoxide dismutase, reduced glutathione, glutathione reductase, Glutathione Peroxidase (GPx) along with total antioxidant activity in vitamin D deficient newly diagnosed Type 2 diabetics. Methods: 150 vitamin D deficient newly diagnosed type 2 diabetics’ and equal number of healthy subjects of both genders were recruited. Fasting blood was collected for evaluation of glucose, 25(OH) D and oxidative stress markers. Results: Significant (P<0.01) increase in malondialdehyde by 51.03% while a significant decrease in oxidative stress markers like SOD, GSH, GR, GPx and total antioxidant activity by 27.91 (P<0.05), 26.14% (P<0.05), 32.04% (P<0.01), 25.41% (P<0.05) and 35.85% (P<0.01) respectively was recorded in vitamin D deficient newly diagnosed type 2 diabetics with respect to healthy controls. Conclusions: A fore mentioned observations suggested that vitamin-D deficient newly diagnosed Type-2 diabetics of North-West Indian’s are associated with oxidative stress, a hallmark of various diseases like Diabetes Mellitus, cardiovascular diseases, osteoporosis etc. Therapeutic interventions in combinations of lifestyle and dietary modification might be beneficial to prevent further risk of development of Diabetes Mellitus and cardiovascular diseases like atherosclerosis in North-West Indians.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"37 1","pages":"1-6"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79910112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study to assess the medication adherence among patients with chronic diseases 慢性疾病患者药物依从性评价研究
IF 1.2 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2021-01-01 DOI: 10.35841/0970-938X.32.4.84-84
Aswathi Sukumar
A true descriptive study was conducted to assess the medication adherence among patients with chronic diseases in selected health care settings at Mangalore", by Mrs. Aswathi Sukumaran as a partial fulfilment of the requirement of the degree of Maters of Science in Nursing at SCS College of Nursing Sciences, Mangalore.
Aswathi Sukumaran女士进行了一项真正的描述性研究,以评估在芒格洛尔选定的卫生保健机构中慢性病患者的药物依从性,作为部分满足芒格洛尔SCS护理科学学院护理理学硕士学位的要求。
{"title":"A study to assess the medication adherence among patients with chronic diseases","authors":"Aswathi Sukumar","doi":"10.35841/0970-938X.32.4.84-84","DOIUrl":"https://doi.org/10.35841/0970-938X.32.4.84-84","url":null,"abstract":"A true descriptive study was conducted to assess the medication adherence among patients with chronic diseases in selected health care settings at Mangalore\", by Mrs. Aswathi Sukumaran as a partial fulfilment of the requirement of the degree of Maters of Science in Nursing at SCS College of Nursing Sciences, Mangalore.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":"686 1","pages":"84-84"},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77036495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Research-tokyo
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1